T&R Biofab Co., Ltd
Founded in 2013 and KOSDAQ-listed in 2018, T&R Biofab commercializes 3D bioprinting systems, bioinks, and biodegradable scaffolds.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureT&R Biofab was founded in 2013 and listed on KOSDAQ in 2018 as a regenerative medicine company. It has commercialized its 3D bioprinting systems, bioinks, and biodegradable scaffolds, and its cosmetics line includes HA (hyaluronic acid) film, HA mask packs, Blisspack HA balls, and PDRN serum. Its business spans three segments—regenerative medicine, bio-surgical solutions, and cosmetics—pairing near-term revenue from bio-surgical solutions with cosmetics as a new growth driver.
Products & technology
- 3D Bioprinting System3D bioprinting system using biocompatible materials and living cells to build layered 3D structures, including cell printing
- BioinkHydrogel material essential for cell printing that keeps loaded living cells viable and functional after printing
- Biodegradable ScaffoldTissue-regenerating scaffold produced with the 3D bioprinting system; degrades in the body and allows tissue ingrowth for reconstruction
- 3D OrganoidOrgan-like 3D structure for in vitro testing
- 3D Cell TherapyCell therapy using biomaterials to mimic a patient's 3D tissue structure, applying or injecting living cells directly
- HA FilmHyaluronic acid (HA)-based cosmetic film
- HA Mask PackHyaluronic acid (HA)-based cosmetic mask pack
- Blisspack HA BallFreeze-dried HA (hyaluronic acid) ball cosmetic product in blister packaging
- PDRN SerumPDRN (polydeoxyribonucleotide)-based cosmetic serum
Regulatory approvals
data.go.kr · openFDA35 Korean MFDS device approvals · 2014–2026 / 2 US FDA 510(k) · 2023–2026
- FDATnR Cranial Implant2026-07-30
- MFDSSurgical supplies2026-01-06Product approval · Class 1제신 26-11 호
- MFDSMesh, polymeric, biodegradable2025-12-09Product approval · Class 4제허 25-829 호
- MFDSHemostat, internal, absorbable2025-09-12Product approval · Class 4제허 25-637 호
- MFDSHemostat, internal, absorbable2025-07-02Product approval · Class 4제허 25-434 호
- MFDSDressing, occlusive, hydrogel2025-06-26Product approval · Class 2제인 25-4570 호
- MFDSHemostat, internal, absorbable2025-05-09Product approval · Class 4제허 25-302 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-11-20Product approval · Class 3제허 24-817 호
- MFDSDressing, occlusive, hydrogel2024-11-07Product approval · Class 2제인 24-1000 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-10-22Product approval · Class 3제허 24-719 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2024-10-15Product approval · Class 3제허 24-697 호
- MFDSDressing, occlusive, hydrogel2024-08-14Product approval · Class 2제인 24-775 호
Show 25 more
- MFDSGraft/prosthesis, biomaterial2024-07-10Product approval · Class 4제허 24-467 호
- MFDSGraft/prosthesis, biomaterial2024-07-10Product approval · Class 4제허 24-466 호
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2024-01-08Product approval · Class 2제인 24-22 호
- FDATHERMOCLICK2023-12-05
- MFDSDressing, occlusive, hydrogel2023-08-30Product approval · Class 2제인 23-5052 호
- MFDSTissue supplement, collagen2023-04-26Product approval · Class 4제허 23-542 호
- MFDSMesh, polymeric, biodegradable2023-04-03Product approval · Class 4제허 23-464 호
- MFDSDressing, occlusive, hydrogel2022-03-24Product approval · Class 2제인 22-4233 호
- MFDSCranioplasty plate, biological/biodegradable2021-02-19Product approval · Class 4제허 21-126 호
- MFDSBarrier, intra oral, resorbable2020-11-12Product approval · Class 4제허 20-961 호
- MFDSSplint, mouldable2020-09-11Product approval · Class 1제신 20-1401 호
- MFDSThermometer, electronic, infrared, skin2020-03-16Product approval · Class 2제인 20-4206 호
- MFDSTissue reconstructive material, synthetic, polymer, absorbable2018-11-08Product approval · Class 4제허 18-725 호
- MFDSCranioplasty plate, biological/biodegradable2017-08-24Product approval · Class 4제허 17-651 호
- MFDSCranioplasty plate, biological/biodegradable2017-08-24Product approval · Class 4제허 17-650 호
- MFDSCranioplasty plate, biological/biodegradable2017-08-24Product approval · Class 4제허 17-648 호
- MFDSCranioplasty plate, biological/biodegradable2017-08-24Product approval · Class 4제허 17-649 호
- MFDSThermometer, electronic, infrared, ear2017-06-01Product approval · Class 2제인 17-4428 호
- MFDSCranioplasty plate, biological/biodegradable2017-05-26Product approval · Class 4제허 17-351 호
- MFDSCranioplasty plate, biological/biodegradable2017-05-12Product approval · Class 4제허 17-312 호
- MFDSBarrier, intra oral, resorbable2017-02-16Product approval · Class 4제허 17-117 호
- MFDSBarrier, intra oral, resorbable2016-11-03Product approval · Class 4제허 16-802 호
- MFDSCranioplasty plate, biological/biodegradable2016-10-10Product approval · Class 4제허 16-745 호
- MFDSThermometer, electronic, infrared, skin2016-05-16Product approval · Class 2제인 16-4397 호
- MFDSCranioplasty plate, biological/biodegradable2014-07-16Product approval · Class 4제허 14-1337 호
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
Founded and KOSPI-listed in 2025, Samyang Biopharm develops medical devices, pharmaceuticals, and new drug candidates.
Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.
Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
Founded in 2016 and listed on KOSDAQ in 2017, DENTIS manufactures dental implants, medical LED lighting, and dental 3D printers.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition